17
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Urogynecological risk assessment in postmenopausal women

&
Pages 625-637 | Published online: 10 Jan 2014

References

  • Dietz HP. Prolapse worsens with age, doesn’t it? Aust. N. Z. J. Obstet. Gynaecol. 48, 587–591(2008).
  • Versi E, Harvey MA, Cardozo L, Brincat M, Studd JWW. Urogenital prolapse and atrophy at menopause: A prevalence study. Int. Urogynecol. J. Pelvic Floor Dysfunct. 12(2), 107–110 (2001).
  • Moalli PA, Shand SH, Zyczynski HM, Gordy SC, Meyn LA. Remodelling of vaginal connective tissue in patients with prolapse. Obstet Gynecol. 106, 953–963 (2005).
  • Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet 347, 1658–1661 (1996).
  • Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet. Gynecol. 109(4), 848–854 (2007).
  • Abrams P, Andersson KE, Birder L et al. Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and faecal incontinence. Neurourol. Urodyn. 29, 213–240 (2010).
  • Srikrishna S, Cardozo L. Patient goals in Urogynecology. Expert Rev. Obstet. Gynecol. 7(4), 327–333 (2012).
  • Rantell A, Cardozo L, Merriman H. NICE guideline on UI may require updating in line with new evidence. Guidel. Pract. 13/9(33), 33–34 (2010).
  • Baden WF, Walker TA, Lindsday HJ. The vaginal profile. Tex. Med. J. 64, 56–58 (1968).
  • Bump RC, Mattiasson A, Bo K et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am. J. Obstet. Gynecol. 175(1), 10–17 (1996).
  • Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol. Urodyn. 21(2), 167–178 (2002).
  • Hall AF, Theofrastous JP, Cundiff GW et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am. J. Obstet. Gynecol. 175(6), 1467–1471 (1996).
  • Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst. Rev. 12, (2011).
  • Abrams P, Andersson KE, Birder L et al. Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol. Urodyn. 29(1), 213–240 (2010).
  • Adams E, Thomson A, Maher C et al. Mechanical devices for pelvic organ prolapse in women. Cochrane Database Syst. Rev. (2) (2004).
  • Abdool Z, Thakar R, Sultan AH, Oliver RS. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int. Urogynecol. J. 22(3), 273–278 (2011).
  • Handa VL, Garrett E, Hendrix S et al. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am. J. Obstet. Gynecol. 190(1), 27–32 (2004).
  • Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women:what is pelvic organ prolapse? Am. J. Obstet. Gynecol. 189(2), 372–377 (2003).
  • Olsen AL, Smith VJ, Bergstrom JO et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet. Gynecol. 89(4), 501–506 (1997).
  • Abdel-Fattah M, Familusi A, Bhattacharya S et al. Epidemiology Of primary and repeat surgical treatment for pelvic organ prolapse and/ or stress urinary incontinence In UK BMJ Open 1(2), e000206 (2011).
  • Singh K, Cortes E, Reid WM. Evaluation of the fascial technique for surgical repair of isolated posterior vaginal wall prolapse. Obstet. Gynecol. 101, 320–324 (2003).
  • Monga A. Management of the posterior compartment. BJOG 111, 73–78 (2004).
  • Maher C, Feiner B, Baessler K et al. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst. Rev. 4, (2010).
  • Costantini E, Lazzeri M, Bini V et al. Pelvic organ prolapse repair with and without concomitant burch colposuspension in incontinent women: a randomised controlled trial with at least 5-year follow up. Obstet. Gynecol. Int. 2012, 967923 (2012)
  • Borstad E, Abdelnoor M, Staff AC et al. Surgical strategies for women with pelvic organ prolapse and urinary stress incontinence. Int. Urogynecol. J. 21(2), 179–186 (2010)
  • Wei JT, Nygaard I, Richter HE, et al.. A midurethral sling to reduce incontinence after vaginal prolapse repair. N. Engl. J. Med. 366(25), 2358–2367 (2012)
  • Price N, Slack A, Jackson SR. Laparoscopic hysteropexy: the initial results of a uterine suspension procedure for uterovaginal prolapse. BJOG 117(1), 62–68 (2010).
  • Davila GW, Baessler K, Cosson M, Cardozo L. Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int. Urogynecol. J. 23(Suppl. 1), S7–S14 (2012).
  • Urogynecologic Surgical Mesh. Update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. FDA 7–11 (2011).
  • Summaries of the Safety/Adverse Effects of Vaginal Tapes/Slings/Meshes for Stress Urinary Incontinence and Prolapse. Final Report. MHRA 33–58 (2012).
  • Harmanli OH, Dandolu V, Chatwani AJ et al. Total colpocleisis for severe pelvic organ prolapse. J. Reprod. Med. 48, 703–706 (2003).
  • Cunningham C. Establishing and Developing a Pelvic Floor Service: the multidisciplinary team and the approach to patient assessment. In: Pelvic Floor Disorders for the Colorectal Surgeon. Lindsay I, Nugent K, Dixon T (Eds). Oxford University Press, 4–5 (2010)
  • Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J. Am. Geriatr. Soc. 46(4), 473–480 (1998).
  • Irwin DE, Milsom I, Hunskaar S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur. Urol. 50(6), 1306–1314 (2006).
  • Mishra GD, Cardozo L, Kuh D. Menopausal transition and the risk of urinary incontinence: results from a British prospective cohort. BJU Int. 106(8), 1170–1175 (2010).
  • NICE. Urinary incontinence: the management of urinary incontinence in women. Clinical Guidelines CG40 (2006).
  • Fink D, Perucchini D, Schaer GN et al. The role of the frequency-volume chart in the differential diagnostic of female urinary incontinence. Acta Obstet. Gynecol. Scand. 78, 254–257 (1999).
  • Winters JC, Dmochowski RR, Goldman HB et al. Urodynamic studies in adults: AUA/SUFU guideline. J. Urol. 188(6 Suppl.), 2464–2472 (2012)
  • Adekanmi OA, Edwards GJ, Barrington JW. The variation in urodynamic practice in the United Kingdom. J. Obstet. Gynecol. 22(1), 48–50 (2002).
  • Okorocha I, Cumming G, Gould I. Female urodynamics and lower urinary tract infection BJU Int. 89(9), 863–867 (2002).
  • Bosch JL, Cardozo L, Hashim H et al. Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol. Urodyn. 30(5), 735–740 (2011).
  • Nager CW, Brubaker L, Litman HJ et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N. Engl. J. Med. 366, 1987–1997 (2012).
  • Martin JL, Williams KS, Abrams KR et al. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol. Assess. 10(6), 1–132 (2006).
  • Wallace SA, Roe B, Williams K et al. Bladder training for urinary incontinence in adults. Cochrane Database Syst. Rev. 1, CD001308 (2004).
  • Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment for urinary incontinence in women. A Cochrane systematic review. Eur. J. Phys. Rehabil. Med. 44(1), 47–63 (2008)
  • Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol. Urodyn. 31(8), 1206–1216(2012).
  • Nabi G, Cody JD, Ellis G et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst. Rev. 4, (2006).
  • Chapple CR, Khullar V, Gabriel Z et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur. Urol. 54(3), 543–562 (2008).
  • NICE. Mirabegron for treating symptoms of overactive bladder. Technology Appraisal Guidance 290 (2013).
  • Cody JD, Richardson K, Moehrer B et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 7(4), CD002111 (2009)
  • Sand PK, Dmochowski RR, Reddy J, et al. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J. Urol. 190(3), 958–964 (2013)
  • Athanasopoulos A. The pharmacotherapy of overactive bladder. Expert Opin. Pharmacother. 12(7), 1003–1005 (2011).
  • Duthie JB, Vincent M, Herbison GP, et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst. Rev. (12) (2011).
  • Brubaker L, Richter HE, Visco A, et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J. Urol. 180(1), 217–222 (2008).
  • Tincello DG, Kenyon S, Abrams KR et al. Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study). Eur. Urol. 62(3), 507–514 (2012).
  • Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J. Urol. 175(3), 835–841 (2006).
  • Kirchin V, Page T, Keegan PE et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 2, CD003881 (2012).
  • Lapitan MC, Cody JD. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst. Rev. 2, CD002912 (2012).
  • Ward KL, Hilton P. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG 115(2), 226–233 (2008).
  • Dean NM, Ellis G, Wilson PD et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst. Rev. 3, CD002239 (2006).
  • Giarenis I, Mastoroudes H, Cardozo L et al. What do we do when a midurethral tape fails? Rediscovery of open colposuspension as a salvage continence operation. Int. Urogynecol. J. 23(8), 1117–1122 (2012).
  • Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst. Rev. 4, CD006375 (2009).
  • Dyrkorn OA, Kulseng-Hanssen S, Sandvik L. TVT compared with TVT-O and TOT: results from the Norwegian National Incontinence Registry. Int. Urogynecol. J. 21(11), 1321–1326 (2010).
  • Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG 114(5), 522–531 (2007).
  • Duckett JR, Papanikolaou NS, Eaton M. The effect of local anaesthetic infiltration on urethral function during the tension-free vaginal tape (TVT) procedure. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19(6), 839–841 (2008).
  • Duckett JR, Tamilselvi A. Effect of tension-free vaginal tape in women with a urodynamic diagnosis of idiopathic detrusor overactivity and stress incontinence. BJOG 113(1), 30–33 (2006).
  • Athanasiou S, Grigoriadis T, Giannoulis G et al. Midurethral slings for women with urodynamic mixed incontinence: what to expect? Int. Urogynecol. J. 24(3), 393–399 (2012).
  • Abdel-Fattah M, Ford JA, Lim CP et al. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur. Urol. 60(3), 468–480 (2011).
  • Rehman H, Bezerra CC, Bruschini H et al. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst. Rev. (1), CD001754 (2011).
  • Pugsley H, Barbrook C, Mayne CJ et al. Morbidity of incontinence surgery in women over 70 years old: a retrospective cohort study. BJOG 112(6), 786–790 (2005).
  • Hextall A, Hooper R, Cardozo L et al. Does the menopause influence the risk of bacteriuria? Int. Urogynecol. J. Pelvic Floor Dysfunct. 12(5), 332–336 (2001).
  • Raz R, Gennesin Y, Wasser J et al. Recurrent urinary tract infections in postmenopausal women. Clin. Infect. Dis. 30(1), 152–156 (2000).
  • Hu KK, Boyko EJ, Scholes D et al. Risk factors for urinary tract infections in postmenopausal women. Arch. Intern. Med. 164(9), 989–993 (2004).
  • Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am. Fam. Physician 71(6), 1153–1162 (2005).
  • Nickel JC, Wilson J, Morales A et al. Value of urologic investigation in a targeted group of women with recurrent urinary tract infections. Can J. Surg. 34(6), 591–594 (1991).
  • Lawrentschuk N, Ooi J, Pang A et al. Cystoscopy in women with recurrent urinary tract infection. Int. J. Urol. 13(4), 350–353 (2006).
  • Hillard T. The postmenopausal bladder. Menopause Int. 16(2), 74–80 (2010).
  • Perrotta C, Aznar M, Mejia R et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Obstet. Gynecol. 112(3), 689–690 (2008).
  • Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst. Rev. 10, CD001321 (2012).
  • Albert X, Huertas I, Pereiró II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst. Rev. CD001209 (2004).
  • Lutters M, Vogt-Ferrier NB. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst. Rev. 3, CD001535 (2008).
  • Pitkin J, Rees M, British Menopause Society Council. Urogenital atrophy. Menopause Int. 14(3), 136–137 (2008).
  • Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet. Gynecol. 92(4), 722–727 (1998).
  • Lifford KL, Curhan GC. Prevalence of painful bladder syndrome in older women. Urology. 73(3), 494–498 (2009).
  • Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/ interstitial cystitis. Cochrane Database Syst. Rev. 4, CD006113 (2007).
  • Hanno PM, Burks DA, Clemens JQ et al. Interstitial Cystitis Guidelines Panel of the American Urological Association Education and Research, Inc.AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J. Urol. 185(6), 2162–2170 (2011).
  • DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am. J. Obstet. Gynecol. 166, 1717–1724 (1992)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.